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Background: The interactions between stem cells and extracellular matrix (ECM) mediated by integrins play
important roles in the processes that determine stem cell fate. However, the role of ECM/integrin interaction in the
formation of embryoid bodies (EBs) during cardiogenesis from murine induced pluripotent stem cells (miPSCs)
remains unclear.
Results: In the present study, collagen type I and β1 integrin were expressed and upregulated synergistically during
the formation of miPSC-derived EBs, with a peak expression at day 3 of differentiation. The blockage of collagen/β1
integrin interaction by β1 integrin blocking antibody resulted in the production of defective EBs that were
characterized by decreased size and the absence of a shell-like layer composed of primitive endoderm cells. The
quantification of spontaneous beating activity, cardiac-specific gene expression and cardiac troponin T (cTnT)
immunostaining showed that the cardiac differentiation of these defective miPSC-derived EBs was lower than that
of control EBs.
Conclusions: These findings indicate that collagen/β1 integrin interaction is required for the growth and cardiac
differentiation of miPSC-derived EBs and will be helpful in future engineering of the matrix microenvironment
within EBs to efficiently direct the cardiac fate of pluripotent stem cells to promote cardiovascular regeneration.
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Embryonic stem cells (ESCs) are characterized by unli-
mited proliferation capacity and multipotency and are one
of the most promising stem cell populations for use in car-
diovascular regenerative medicine. However, the use of
ESCs is hampered by their embryonic origin and by the
potential immune rejection of allogeneic cell grafts. These
issues may potentially be circumvented by the use of
induced pluripotent stem cells (iPSCs) that are repro-
grammed from somatic cells by the ectopic expression of
4 transcription factors (Oct4, Sox2, c-Myc, and Klf4) [1,2].
The use of iPSCs allows the generation of patient-specific
cells of any lineage that is not derived from embryos.
iPSCs have a differentiation capacity similar to that of
ESCs and were shown to be capable of differentiating into* Correspondence: qiangsunzheng@gmail.com
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reproduction in any medium, provided the orfunctional cardiomyocytes through embryoid body (EB)
formation [3,4]. EB formation has been utilized widely as a
trigger of in vitro differentiation in ESCs and iPSCs and is
a critical intermediate step in the induction of lineage-
specific differentiation [5]. The importance of EB formation
is further demonstrated by findings that lineage-specific dif-
ferentiation programs within EBs closely resemble lineage
commitment programs in the developing embryo [6,7].
Lineage-specific differentiation within EBs is a response
to a variety of environmental stimuli, including cell-cell
adhesion and cell-matrix interactions. Recent strategies
for engineering EB formation have focused primarily on
controlling EB size, extracellular matrix (ECM) interac-
tions and cell-cell adhesion [8]. Processes that determine
cell fate are often mediated by the ECM, and such
mediation has been studied largely by seeding ESCs or
EBs within natural ECM hydrogel materials [9,10]. Native
ECM components such as collagen, fibronectin and lami-
nin direct cell differentiation through integrin-mediatedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 2 EB formation by mESCs and miPSCs. 3-day and 5-day-
old EBs derived from mESCs and miPSCs via the hanging drop method
(A) and static suspension culture (B). Insets: fluorescent micrographs of
miPSC-derived EBs that expressed Oct4-eGFP. Scale bars = 200 μm.
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cascades that ultimately lead to gene expression changes
that modulate cell phenotype [12]. ECM/integrin interac-
tions have been shown to influence stem cell differentiation,
attachment and proliferation during early embryonic deve-
lopment [9,13]. However, little is known regarding the role
of ECM/integrin interactions in the growth and cardiac
lineage commitment of iPSC-derived EBs that closely re-
semble corresponding processes in the developing embryo.
The objective of the present study was to explore the role
of collagen/β1 integrin interaction in EB formation from
miPSCs and the involvement of such interaction in the dif-
ferentiation of miPSCs into cardiomyocytes.
Results
Collagen and β1 integrin are expressed synergistically
during EB formation
The morphology of the undifferentiated miPSC colonies
carrying the GFP transgene targeted to the Oct4 locus
closely resembled that of the mESCs growing on either
MEFs or gelatin-coated dishes under feeder-free condi-
tions and expressing green fluorescent protein (GFP)
(Figure 1A). To induce cardiac differentiation, the miPSCs
and mESCs were cultured via the hanging drop method
or static suspension to form three-dimensional embryoid
bodies (EBs) (Figure 1B). Through both of these culture
systems, EBs resembling those derived from mESCs were
generated from the miPSCs on day 3 and 5 of differen-
tiation (Figure 2A, B).
To explore the role of collagen/integrin interactions in
EB formation, the expression of collagen and of its integ-
rin receptors (α1, α2, β1) was determined by semiquantita-
tive RT-PCR in undifferentiated mESCs, miPSCs, and EBs.
Undifferentiated mESCs and miPSCs expressed Itga1 and
Itgb1 (integrin α1, β1), whereas Col1A1, Col1A2, Col3A1
and Itga2 were not expressed (Figure 3A). During EB for-
mation, the expression of Col1A1 and Itgb1 was upregu-
lated and peaked on day 3 of differentiation, then fell to
levels equal to those in mESCs and miPSCs on day 5Figure 1 Cell culture of mESCs and miPSCs. (A) Morphology of undiffer
coated plates. (B) Scheme of EB formation via the hanging drop method a(Figure 3A). Real-time PCR results confirmed that Col1A1
and Itgb1 were expressed in a temporal pattern with a
peak on day 3 during EB formation (Figure 3B, C). The
expression of Itga1 (an α subunit of collagen receptor) was
not upregulated but reduced on day 5 during EB formationentiated miPSCs and mESCs cultured on MEF feeder layers or gelatin-
nd static suspension culture as described in Materials and Methods.
Figure 3 Expression patterns of collagen and integrins during EB formation. (A) mRNA expression of collagen (Col1A1, Col1A2, Col3A1) and
its integrin receptors (Itga1, Itga2, Itgb1) determined by semiquantitative RT-PCR. (B to D) Real-time PCR analysis of Col1A1, Itga1 and Itgb1,
normalized to β-actin, in mESCs, miPSCs, and EBs (days 3 and 5). Experiments were performed in triplicate. *Significant at p < 0.05. (E)
Immunostaining of collagen type I in miPSC-derived EBs on day 3. Scale bars = 200 μm.
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strated the expression of collagen type I (Figure 3E). These
findings suggest that collagen type I and β1 integrin were
expressed temporarily and synergistically during EB
formation in mESCs and miPSCs.
β1 integrin blocking inhibits the growth and shell
formation of miPSC-derived EBs
Because ECM/integrin interactions have been shown to
influence stem cell differentiation during early embryonic
development [9,13], we hypothesized that collagen/β1 in-
tegrin interaction may play a similar role in EB formation,
which closely resembles embryonic development. To test
this hypothesis, we administered 100 μM Vc, 300 μM CIS
and 10 ng/ml β1 integrin blocking antibody to respectively
promote collagen synthesis, inhibit collagen synthesis, and
block collagen/β1 integrin interaction prior to EB forma-
tion (Figure 4A). Size analysis showed that the mean
diameter of the EBs produced in static suspension culture
was larger in the Vc group and smaller in the CIS and β1
integrin blocking groups compared with the control group
(P < 0.05, Figure 4A, B). On day 5 of differentiation, the
mean diameter of EBs was 263.3 ± 59.6 μm in the Vc
group, 179.6 ± 30.3 μm in the CIS group, and 222.7 ± 42.1
μm in the control group. β1 integrin blocking led to
a marked decrease in EB size to 127.0 ± 22.2 μm
(Figure 4B). The mean diameter of EBs produced via the
hanging drop method was not significantly altered by β1integrin blocking (data not shown). Phase-contract and
fluorescent micrographs of miPSC-derived EBs formed
after β1 integrin blocking revealed a loose outer layer lac-
king a dense shell as observed in control EBs (Figure 4C).
Scanning electron micrographs revealed the formation of
a smooth outer layer resulting from extracellular matrix
deposition in control EBs (day 5), in contrast to a cilium-
like surface topography lacking a dense shell-like layer in
EBs formed after β1 integrin blocking (Figure 4D).
Decreased cardiac differentiation of miPSC-derived EBs
after β1 integrin blocking
To assess whether blocking of collagen/β1 integrin inter-
action during EB formation affects the cardiac lineage com-
mitment of miPSCs, miPSC-derived EBs formed with or
without β1 integrin blocking were differentiated using a
standard protocol (Figure 5A). From day 6 to day 28 of
differentiation, plated EBs were examined for spontaneous
beating activity. During the time course of cardiac diffe-
rentiation, the percentage of beating EBs in the β1 integrin
blocking group was lower than that in the control group
(Figure 5B). The percentage of beating EBs continued to
increase until day 16 of differentiation and reached plateau
values of 18.0 ± 3.0% in the β1 integrin blocking group and
33.8 ± 4.4% in the control group. On day 21, the beating
EBs were immunostained for cardiac troponin T (cTnT) to
characterize the cardiac-specific protein. This immunos-
taining revealed organized sarcomeric myofilaments in the
Figure 4 Blocking of collagen/β1 integrin interaction inhibits the growth and shell formation of miPSC-derived EBs. (A) Morphology of
miPSC-derived EBs after treatment with Vc (collagen stimulator), CIS (collagen inhibitor) or β1 integrin blocking antibody. β1 integrin blocking
resulted in delayed growth of EBs and a rough edge. (B) Size analysis revealed that the mean diameter of EBs, compared with that of the control
group, was larger in the Vc group and smaller in the CIS and β1 integrin blocking groups (*p < 0.05). The data were obtained from five sample
EBs per field in 10 fields, and three independent experiments were performed. (C) Phase-contrast and fluorescent micrographs of miPSC-derived
EBs grown as hanging drop with or without β1 integrin blocking. Arrows indicate the loose outer layer and the absence of a dense shell. (D)
Scanning electron micrographs of 5-day-old EBs with or without β1 integrin blocking. A fibrous ECM coating and a smooth exterior were
observed in control EBs (left column). In contrast, the surface topography of EBs with β1 integrin blocking was characterized by a cilium-like
structure and the absence of a dense shell-like layer (right column). Scale bars = 200 μm.
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unorganized myofilaments in the β1 integrin blocking
group (Figure 5C).
To characterize the cardiomyocyte phenotype, we
included a series of marker genes in the study. GATA-
binding protein 4 (GATA-4), NK2 transcription factor
related locus 5 (Nkx2.5), and myocyte enhancer factor 2C
(Mef2c) were included as markers for cardiac mesoderm.
α-myosin heavy chain (α-MHC) and myosin light chain 2
atrial and ventricular transcripts (MLC2a, MLC2v) were
included as markers for cardiomyocytes. The semiquanti-
tative RT-PCR and real-time PCR results both demon-
strated that all of the above cardiac-specific markers were
decreased significantly in the miPSC-derived EBs formed
after β1 integrin blocking (Figure 5D, E). These findings
indicate that blocking of collagen/β1 integrin interaction
during EB formation leads to decreased cardiac differenti-
ation of miPSCs.Discussion
EB formation, which recapitulates various aspects of
early embryonic development and displays a high degree
of self-organization [14], has been commonly used to in-
duce lineage-specific differentiation of ESCs and iPSCs.
The typical characteristics of EB formation, such as EB
size and shape, are important parameters that influence
cardiac lineage commitment [15-17]. Collagen, the major
component of ECM, has been shown to enhance cardiac
cell engraftment [18] and cardiac differentiation [19]
through integrin-mediated interactions between the cells
and collagen. There is increasing evidence that ECM/in-
tegrin interactions are essential for stem cell differ-
entiation, attachment and proliferation during early
embryonic development [9,13]. We hypothesized that
collagen/β1 integrin interaction plays an essential role in
the formation and cardiac differentiation of iPSC-
derived EBs, which closely resembles early embryonic
Figure 5 Decreased cardiac differentiation of miPSC-derived EBs formed after blocking of collagen/β1 integrin interaction. (A)
Schematic protocol of cardiac differentiation from miPSCs. Vc, CIS or β1 integrin blocking antibody was administered prior to EB formation. (B)
Time course quantification of spontaneous beating activity of differentiated cardiomyocytes was expressed as the percentage of beating EBs.
Error bars indicate SEM. (C) Immunostaining for cardiac troponin-T (cTnT) of miPSC-derived cardiomyocytes on day 21. Nuclei were
counterstained with DAPI (blue). Scale bars = 20 μm. (D, E) Gene expression profiles of cardiac-related transcription factors (GATA-4, Mef2c,
Nkx2.5) and cardiac-specific structural genes (α-MHC, MLC2a, MLC2v) were analyzed by semiquantitative RT-PCR (D) and real-time PCR (E).
Treatment with β1 integrin blocking antibody decreased the expression of these factors and genes. Expression levels of each gene were
normalized to β-actin or GAPDH. Mean fold change relative to control and SD from triplicate experiments are shown. *p < 0.05 relative to control.
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expression patterns of collagen and integrins during EB
formation. Our findings, consistent with those of a pre-
vious study [20], showed that undifferentiated mESCs
and miPSCs expressed integrin α1 and β1 but not integ-
rin α2. During EB formation, collagen and β1 integrin
were upregulated synergistically and peaked on day 3 of
differentiation, suggesting that the collagen/β1 integrin
interaction may be involved in EB formation.
We used two common culture techniques, the hanging
drop method and static suspension. Static suspension
culture is performed by adding a suspension of ESCs or
iPSCs to a bacteriological Petri dish and allowing the cells
to aggregate spontaneously via cell-cell adhesion [21]. Thismethod was used to assess the effect of collagen/β1 integrin
interaction on the growth of miPSC-derived EBs. The size
and shape of the EBs resulting from static suspension cul-
ture tend to be heterogeneous [21], and this phenomenon
has been shown to influence cardiac lineage-specific diffe-
rentiation [15-17]. Such heterogeneity is avoided by the
hanging drop method, in which a defined number of
isolated mESCs or miPSCs are added to a drop where they
aggregate [22]. To exclude the confounding effect of size
heterogeneity on cardiac differentiation, we used the hang-
ing drop method to investigate the effect of collagen/β1 in-
tegrin interaction on the cardiac differentiation of miPSCs.
The size analysis of EBs formed by static suspension
culture showed that EB size was increased by treatment
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by treatment with CIS (a collagen inhibitor), indicating
that collagen synthesis is potent regulator of EB growth.
Treatment with β1 integrin blocking antibody produced
a greater decrease in EB size, indicating the essential role
of collagen/β1 integrin interaction in the control of EB
size. The size of EBs formed by the hanging drop
method was not affected by treatment with β1 integrin
blocking antibody. However, the EBs formed by this
method following β1 integrin blocking did not form a
dense shell-like layer as is observed in normal EBs
[23,24]. During EB formation, a layer of primitive endo-
derm is often formed on the exterior surface following
cell aggregation [25]. Consistent with our observation
that EBs failed to form a dense shell-like layer following
β1 integrin blocking, another recent study demonstrated
that β1 integrin blocking in differentiating EBs resulted
in the detachment of this endoderm layer from the EB
surface [26].
Because EB size and shape have been shown to play
essential roles in cardiac lineage commitment [15-17],
we investigated whether β1 integrin blocking during EB
formation affects the cardiac lineage commitment of
miPSCs. A study of spontaneous beating activity, the
quantification of cardiac-specific gene expression and
cTnT immunostaining all revealed decreased cardiac
differentiation in miPSC-derived EBs formed after the
blocking of collagen/β1 integrin interaction. In addition,
we also assessed some markers related to the structural/
maturity characteristics of cardiomyocytes, such as cTnI,
MLC2a, and MLC2v. cTnT staining showed that iPSCs-
derived cardiomyocytes failed to form organized sarco-
meric myofilaments with β1 integrin blocking as that in
the control group (Figure 5C), and measurement of
MLC2a and MLC2c revealed decreased expression after
integrin β1 disruption (Figure 5D, E). Moreover, orga-
nized myofilaments and high MLC2v expression are also
considered as markers for mature cardiomyocytes [27].
These results suggested that the structure and maturity
of iPSCs-derived cardiomyocytes were impaired by
integrin β1 blocking. In conclusion, our findings indicate
that collagen/β1 integrin interaction is required for the
growth and cardiac differentiation of miPSC-derived
EBs. This information will be helpful in future engineer-
ing of the EB microenvironment to promote the cardiac
differentiation of pluripotent stem cells.
In the developing embryo, the native ECM plays a central
role by mediating biophysical stimuli, biochemical and
molecular signals and spatial organization. The process of
constant interchange between cells and the ECM, termed
dynamic reciprocity, determines cell fate and triggers the
shift from proliferation to structure formation [28]. As
main components of native ECM, collagen may be involved
in the development of many organs through integrin-mediated signaling events. Our results revealed that integ-
rin β1 disruption resulted in decreased cardiomyocytes dif-
ferentiation, but whether other cell lineages will be affected
by integrin β1 disruption remained to be further investi-
gated (Additional file 1: Figure S1). Moreover, the potential
mechanism remained unclear, although we excluded the
possibility that the loss of pluripotency is not affected by
integrin β1 blocking (Additional file 2: Figure S2). These
effects of integrin disruption may relate to the loosely
formed EBs which lack some structure that are essential
for cardiogenesis.
Conclusions
In summary, our study demonstrated that blockage of
collagen/β1 integrin interaction inhibited the quality and
growth of miPSC-derived EBs, resulting in reduced EB
size and decreased cardiac differentiation potential.
These findings indicated the essential role of collagen/β1
integrin interaction in cardiac lineage commitment of
miPSCs during EB formation, and will shed light on
engineering matrix microenvironment within EBs to effi-
ciently direct the cardiac fate of pluripotent stem cells.
Methods
Culture of mESCs and miPSCs
The miPSCs used in this study (kindly provided by
Duanqing Pei, Chinese Academy of Sciences), which carry
the GFP transgene targeted to the Oct4 locus, were gene-
rated by retroviral transduction of adult fibroblasts from
OG2 mice with pMX-based retroviral vectors encoding
the transcription factors Oct4 and Sox2. Undifferentiated
mESCs (CGR8) and miPSCs were cultured on a mitoti-
cally inactivated mouse embryonic fibroblast (MEF; 50,000
cells/cm2) feeder layer or on gelatin-coated dishes as des-
cribed previously [29]. The culture medium consisted of
85% knockout high-glucose glutamine-free DMEM with
sodium pyruvate, supplemented with 15% serum replace-
ment, 2 mM GlutaMAX, 0.1 mM nonessential amino acid
stock, 0.1 mM β-mercaptoethanol (all from Invitrogen,
Carlsbad, CA), and 1000 U/ml murine leukemia inhibitory
factor (Chemicon, Temecula, CA). The culture medium
was changed daily, and the cells were passaged every 2–3
days to maintain their undifferentiated state.
EB formation via hanging drop method and static
suspension culture
Before the initiation of differentiation, mESC and miPSC
colonies were passaged up to 3 times on gelatin-coated
dishes without feeder cells to eliminate contaminating
MEFs. Before EB induction, adherent cells were enzyma-
tically dissociated into single cells using 0.05% Trypsin-
EDTA (Invitrogen). For the hanging drop method, EBs
were formed in hanging drops consisting of 500 cells in
20 μl of differentiation medium. For static suspension
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(EBs) using a 3-dimensional culture system in the diffe-
rentiation medium on uncoated Petri dishes (Greiner
Bio-One, Monroe, NC). At day 3 of differentiation, the
EBs were transferred onto ultra-low attachment 6-well
plates (Corning, Cat. No. 3471) in suspension culture for
2 additional days. The differentiation medium was based
on high-glucose glutamine-free DMEM and supplemen-
ted with 20% ES-qualified fetal bovine serum (Hyclone,
Logan, UT), 2 mM GlutaMAX, 0.1 mM nonessential
amino acid stock, and 0.1 mM β-mercaptoethanol.
To elucidate the role of collagen/β1 integrin interaction
in EB formation, ascorbic acid (Vc, collagen stimulator;
100 μM, Sigma) or cis-4-hydroxy-D-proline (CIS, collagen
inhibitor; 300 μM, Sigma) was administered prior to EB
formation. In some experiments, 10 μg/ml β1 integrin
blocking antibody (clone Ha2/5, BD Pharmingen) was
administered to block collagen/β1 integrin interaction.
Morphological analysis of EBs
Gross morphology was analyzed to determine whether the
blocking of collagen/β1 integrin interaction affected the
growth of EBs from mESCs and miPSCs. Images of EBs
formed by the hanging drop method and by static suspen-
sion culture under various conditions were obtained on
days 3 and 5. For size analysis, mean diameters were mea-
sured using the Image J software program and calculated
from more than five sample EBs per field in 10 fields as
described previously [30]. When the significant differences
were analyzed, the maximum and minimum of diameters
in each group were removed to avoid large error. Three or
more independent experiments were performed for each
time point.
Cardiac differentiation of EBs
Day 5 EBs were plated on 0.1% gelatin-coated 6-well
culture plates at a density of ≈ 10 EBs per well. Starting
at day 6 of differentiation, the differentiation medium
described above was replaced every second day, and
each EB outgrowth was examined daily for areas that
displayed spontaneous beating.
Immunocytochemistry
Whole EBs (day 3) and plated EBs (day 21) were stained
to detect collagen and cardiomyocyte proteins, respect-
ively. For Collagen I staining, whole iPSCs-derived EBs
(day 3) were fixed in 4% paraformaldehyde for 40 min
and embedded for frozen sectioning using OCT. Plated
EBs (day 21) were fixed in 4% paraformaldehyde for 15
minutes at room temperature. All samples were permea-
bilized in 0.1% Triton X-100 for 10 minutes, and then
blocked with 5% BSA for 30 minutes. The cells were
incubated overnight with rabbit monoclonal anti-cardiac
troponin T antibody (cTnT; Abcam, 1:100) and rabbitmonoclonal anti-collagen type I antibody (Abcam,
1:100). After incubation overnight, we identified that
there were no Oct4-GFP residue in samples using a
fluorescence microscope before incubation with the
FITC-conjugated secondary antibody. The bound anti-
bodies were visualized by incubation with the appro-
priate secondary antibody (goat anti-rabbit IgG-FITC;
Abcam, 1:500) for 40 minutes at 37°C. Then the cells
were counterstained with DAPI (Sigma, 1:1000) and ana-
lyzed using a fluorescence microscope.
Semiquantitative RT-PCR and quantitative real-time PCR
Total RNA was extracted from EBs using Trizol reagent
(Invitrogen) according to the manufacturer’s instruc-
tions. Following treatment with Recombinant DNAse I
(Takara, Japan) to remove genomic DNA contamination,
400 ng/μl RNA was reverse transcribed using the Prime-
Script™ First Strand cDNA Synthesis Kit (Takara). The
resulting cDNA was amplified by polymerase chain reac-
tion (PCR) using standard methods. Primer sequences
and PCR conditions are detailed in Additional file 3:
Table S1 and Additional file 4: Table S2. mRNA levels of
the target genes were normalized to β-actin or GAPDH.
Three replicates were performed for each time point.
SYBR Green real-time PCR studies were performed
using SYBR Premix Ex Taq™ II (Takara). All experiments
were conducted in triplicate. Samples were subjected to
the following cycle 40 times: 5 minutes at 95°C; 40 cycles
of 30 seconds at 95°C, 30 seconds at 60°C, and 30 seconds
at 72°C; a final step of 10 minutes at 72°C and 5 minutes
at 4°C. The size of amplicons and the absence of nonspeci-
fic products were measured or confirmed using melting
curves and gel electrophoresis. The transcripts for β-actin
and GAPDH were used for internal normalization. Rela-
tive quantification was performed by the △△CT method.
Scanning electron microscopic analysis
mESCs and miPSC-derived EBs (days 3 and 5) were
fixed for 2 h in 2.5% glutaraldehyde diluted in sodium
cacodylate buffer (Electron Microscopy Sciences) and
post-fixed with 1% osmium tetroxide buffered with 0.1
M sodium cacodylate for 1 h. The fixed samples were
dehydrated using a series of ethanol solutions of increa-
sing concentration (50%, 70%, 80%, 95%, 100%), critically
point dried with CO2, and sputter-coated for 120 s at 2.0
KV using a Polaron SC7640 sputter coater. The samples
were observed and photographed using a Philips XL20
scanning electron microscope.
Statistical analysis
The results are presented as the mean ± SEM. The data
were analyzed by Student’s t-test or 1-way ANOVA with
repeated-measures analysis. For all analyses, differences
with p values < 0.05 were considered statistically significant.
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Additional file 1: Figure S1. Expression of markers related to three
germ layer within EBs. Semiquantitative RT-PCR measurement of markers
related to the three germ layer (endoderm: a-Fetoprotein, GATA-6;
mesoderm: Brachyury; ectoderm: TuJ1, Map2) within 3d- and 5d-EBs
derived from cells subject to integrin disruption and controls.
Experiments were performed in triplicate, and the transcripts for GAPDH
were used for internal normalization.
Additional file 2: Figure S2. Loss of pluripotency within EBs after
integrin disruption. Semiquantitative RT-PCR (A) and quantitative PCR (B,
C) measurement of pluripotent markers (OCT3/4 and Nanog) within 3d-
and 5d-EBs derived from cells subject to integrin disruption and controls.
Expression levels of each gene were normalized to GAPDH. Mean fold
change relative to GAPDH and SD from triplicate experiments are shown.
Additional file 3: Table S1. Primers and cycling conditions for RT-PCR.
Additional file 4: Table S2. Primers for RT-PCR in supplementary
figures.
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